Clinical Trials

Showing trials with last updates posted in 2026.

NCT07491497 | RECRUITING | PHASE1/PHASE2
160 participants

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2026-03-11
Completion:
2029-05-31
Conditions
  • ALK-positive NSCLC
  • ALK-Positive Lung Cancer
  • ALK-positive Non-small Cell Lung Cancer
Interventions
  • DRUG
No Results Yet
NCT07446595 | ACTIVE_NOT_RECRUITING | NA
16 participants

BfedBwell INSPIRE Pilot

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2026-08-11
Completion:
2027-03-31
Conditions
  • Cancer Survivorship
  • Overweight , Obesity
Interventions
  • BEHAVIORAL
No Results Yet
NCT07444710 | NOT_YET_RECRUITING | PHASE1
16 participants

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-03
Start Date:
2026-10-30
Completion:
2027-09-01
Conditions
  • Ann Arbor Stage II Mantle Cell Lymphoma
  • Ann Arbor Stage III Mantle Cell Lymphoma
  • Ann Arbor Stage IV Mantle Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page